Moderna
MRNA
#290
Rank
โ‚ฌ71.92 B
Marketcap
177,76ย โ‚ฌ
Share price
-2.17%
Change (1 day)
763.09%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚ฌ3.82 Billion

According to Moderna 's latest financial reports the company's total liabilities are โ‚ฌ3.82 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ3.13 B0.8%
2024-12-31โ‚ฌ3.11 B-24.69%
2023-12-31โ‚ฌ4.13 B-34.13%
2022-12-31โ‚ฌ6.27 B-32.43%
2021-12-31โ‚ฌ9.29 B139.32%
2020-12-31โ‚ฌ3.88 B949.13%
2019-12-31โ‚ฌ0.37 B-1.97%
2018-12-31โ‚ฌ0.37 B-1.35%
2017-12-31โ‚ฌ0.38 B-30.03%
2016-12-31โ‚ฌ0.54 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ105.65 B 2,659.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ72.54 B 1,794.88%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚ฌ80.05 B 1,990.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚ฌ5.28 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚ฌ39.94 M-98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ4.00 B 4.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ1.50 B-60.81%๐Ÿ‡บ๐Ÿ‡ธ USA